Rhumbline Advisers reduced its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 10.0% during t...
Harbor Capital Advisors Inc. bought a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in ...
Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have received an average rating of “Buy” fr...
Here is how Astellas Pharma Inc. (ALPMY) and AtriCure (ATRC) have performed compared to their sector...
Shares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have earned a consensus recommendation of "...